Recently diagnosed with HIV? Click here

Anal cancer

Displayed below is content from the NAPWA website tagged with the keyword anal cancer.

Anal cancer too high among PLHIV

Positive Living article • David Menadue • 6 December 2012
symptoms, illnesses and opportunistic infections

‘Unacceptably high’ is how a world expert on anal cancer describes the current rates of anal cancer amongst HIV positive people.

‘In the US we are seeing rates of around 100 cases per 100,000’, Professor Joel Palefsky from the University of California told a session at the recent Australasian HIV/AIDS Conference in Melbourne. read more »

Anal cancer screening needed

Positive Living article • Adrian Ogier • 26 May 2011
symptoms, illnesses and opportunistic infections

Research conducted by the Kirby Institute at UNSW (formerly the National Centre in HIv epidemiologyThe branch of medical science that deals with the study of incidence and distribution and control of a disease in a population. and ClinicalPertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science. Research) has shown that the annual incidence of anal cancer in Australia has increased by almost 50% in the last 20 years. read more »

Topical treatment for pre-anal cancer

Positive Living article • www.aidsmap.org • 4 December 2009
symptoms, illnesses and opportunistic infections

A course of topical trichloroacetic acid appears to provide a safe and effective treatment for anal intraepithelial neoplasia (AIN) – the name given to pre-cancerous cell changes in the anus, US investigators report.

Higher rates of anal cancer are seen in gay men, especially those with HIV. The treatment, however, proved just as effective on both positive and negative men. read more »

Saving your arse

Positive Living article • Peter Watts • 5 June 2009

HIV is a sneaky bugger. As soon as we think we’ve got it cornered, other complications emerge. Now, it transpires that even on successful treatment we’re still more susceptible to particular cancers. PETER WATTS investigates. read more »

ASHM 2008: Immune deficiency driving growth of anal cancer

Positive Living article • David Menadue • 25 November 2008

Unlike many diseases that have disappeared with the advent of HAARTHighly Active AntiRetroviralA medication or other substance which is active against retroviruses such as HIV. Therapy ??? aggressive treatment of HIV infection using several different drugs together., anal cancer has not, with rates in HIV-positive gay men now sitting at 1 in 1000, which is greater than rates of cervical cancer. read more »

CROI 2007: A great leap forward

Positive Living article • Paul Kidd • 22 March 2007

A major scientific conference on HIV has wound up with promising news on treatments which could signal a significant improvement in HIV treatment for the first time in some years. read more »

On the shoulders of giants

Positive Living article • Paul Kidd • 13 October 2005

The annual conference of the Australasian Society for HIV Medicine (ASHMAustralasian Society for HIV Medicine. The peak Australasian organisation representing the medical and health sector in HIV/AIDS and related areas. ) was held in Hobart, Tasmania, from 24-27 August. read more »

Syndicate content
Text size: font smallerfont normalfont larger

Stay in touch

NAPWHA's email newsletters provide regular info about issues affecting people with HIV and the response to HIV in Australia. Click here to subscribe.

Subscribe to Positive Living

Our free quarterly newsmagazine, Positive Living provides authoritative, independent information about living with HIV and HIV treatments. Click here to subscribe.

RSS feeds

Our website has RSS feeds covering all topic areas — just go to the topic area you're interested in and click the RSS feed icon.

Twitter users can stay up-to-date with NAPWHA's work and be alerted to new content on the website by following @napwa.

Join us on Facebook NAPWHA Facebook.

Find out more at LinkedIn

Find out more about NAPWHA at LinkedInNAPWHA at LinkedIn.

HIV Clinical Trials update